
TIDDIES (TIDDIES) price today
Live TIDDIES chart
TIDDIES (TIDDIES) price details

TIDDIES price history
TIDDIES technical analysis
TIDDIES (TIDDIES) sentiment
About TIDDIES
Official links
Social media and community
FAQ
1. What is the current price of TIDDIES (TIDDIES) in USD?
2. What is the market capitalization of TIDDIES (TIDDIES)?
3. What is the circulating supply of TIDDIES (TIDDIES)?
4. What factors influence the price of TIDDIES (TIDDIES)?
5. Is TIDDIES (TIDDIES) a good investment?
6. Where can I buy TIDDIES (TIDDIES)?
7. What are the typical fees when buying TIDDIES (TIDDIES)?
8. What are some technical indicators used for analyzing TIDDIES (TIDDIES)?
Currency price converter
Popular
How to buy
TIDDIES news
Democratic Party's AI Regulation Push Revealed: Plans for Intensive Legislation and Strict Scrutiny of Tech Giants
PFE Stock: Pfizer’s Q3 2026 Earnings, Business Strategy, and Dividend Outlook
PFE is the New York Stock Exchange ticker for Pfizer Inc. In the third quarter of 2026, Pfizer reported revenue of $16.58 billion and adjusted earnings per share of $0.87, both above market expectations. The company raised its full-year revenue outlook to $62 billion–$64 billion and its adjusted EPS guidance to $2.95–$3.05, pointing to stronger performance than previously expected.
Although demand for COVID-related products continues to decline, Pfizer’s non-COVID business is growing. Third-quarter sales reached $720 million for the cancer drug Padcev and $2.52 billion for Eliquis, up 25% year over year. Revenue from newer and acquired products rose 32%. Pfizer is expanding its oncology pipeline, entering the weight-loss treatment market through its acquisition of Metsera, and targeting approximately $9.7 billion in net cost savings by 2029. Cecile Guegan has also taken over as chief financial officer.
Investors are also watching Pfizer’s dividend and legal developments. The company declared a cash dividend of $0.43 per share, with an ex-dividend date of November 6, 2026. Analysts raised some earnings estimates and price targets following the quarterly results. Pfizer also faces ongoing legal scrutiny related to statements about COVID vaccine safety, while its subsidiary Mylan has sued Novo Nordisk over generic-drug patent issues involving Wegovy. Pfizer’s outlook depends on new-product growth, cost savings, patent matters, and litigation developments. This article is for informational purposes only and is not investment advice.
South Korea’s GOPAX halts crypto trading, withdrawals after hacking threat
Bhutan: A royal decree opens the future central bank's reserves in Gelephu to cryptocurrencies
Bhutan equips Gelephu Mindfulness City with a central bank authorized to hold cryptocurrencies in reserve, backed by the kingdom's hydropower mining.
Website
X(Twitter)











